Doxorubicin Hydrochloride
AREN0321
Phase 2 small_molecule completed
Quick answer
Doxorubicin Hydrochloride for Childhood Renal Cell Carcinoma is a Phase 2 program (small_molecule) at Children's Hospital of Fudan University with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Children's Hospital of Fudan University
- Indication
- Childhood Renal Cell Carcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed